Literature DB >> 9735399

Allelic loss on chromosome 22 in oral cancer: possibility of the existence of a tumor suppressor gene on 22q13.

A Miyakawa1, X L Wang, H Nakanishi, F L Imai, M Shiiba, T Miya, Y Imai, H Tanzawa.   

Abstract

In order to understand the detail of genetic alternation on chromosome 22, we performed polymerase chain reaction analysis of microsatellite polymorphisms corresponding to 13 loci on chromosome 22. We examined 33 primary carcinoma tissues, 5 metastatic tissues and corresponding normal tissues. We detected microsatellite instability (MI) in 14 (42.4%) of 33 cases in this study. Loss of heterozygosity (LOH) was observed in at least one locus in 24 (72. 7%) of the 33 cases. Among the loci examined, LOH was restricted to D22S274 on chromosome 22q13 in 11 (40.7%) of 27 informative cases. No significant correlation between histological differentiation and LOH was observed. These observations suggest that the incidence of LOH at chromosome 22q is high and is associated with the carcinogenesis of oral squamous cell carcinoma (SCC). The D22S274 locus may play an important role in the development of oral SCC and be the site harboring a putative tumor suppressor gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9735399     DOI: 10.3892/ijo.13.4.705

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

1.  Human pancreatic islets express mRNA species encoding two distinct catalytically active isoforms of group VI phospholipase A2 (iPLA2) that arise from an exon-skipping mechanism of alternative splicing of the transcript from the iPLA2 gene on chromosome 22q13.1.

Authors:  Z Ma; X Wang; W Nowatzke; S Ramanadham; J Turk
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

2.  PHF21B as a candidate tumor suppressor gene in head and neck squamous cell carcinomas.

Authors:  Fernanda Bernardi Bertonha; Mateus de Camargo Barros Filho; Hellen Kuasne; Patricia Pintor Dos Reis; Erika da Costa Prando; Juan José Augusto Moyano Muñoz; Martín Roffé; Glaucia Noeli Maroso Hajj; Luiz Paulo Kowalski; Claudia Aparecida Rainho; Silvia Regina Rogatto
Journal:  Mol Oncol       Date:  2014-10-13       Impact factor: 6.603

3.  Detailed deletion mapping of loss of heterozygosity on 22q13 in sporadic colorectal cancer.

Authors:  Hai-Tao Zheng; Zhi-Hai Peng; Chong-Zhi Zhou; Da-Peng Li; Zhao-Wen Wang; Guo-Qiang Qiu; Lin He
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

4.  Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma.

Authors:  Chong-Zhi Zhou; Zhi-Hai Peng; Fang Zhang; Guo-Qiang Qiu; Lin He
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

5.  ATF4 loss of heterozygosity is associated with poor overall survival in medullary thyroid carcinoma.

Authors:  Michelle D Williams; Junsheng Ma; Elizabeth G Grubbs; Robert F Gagel; Rozita Bagheri-Yarmand
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

6.  Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma.

Authors:  K Hamana; K Uzawa; K Ogawara; M Shiiba; H Bukawa; H Yokoe; H Tanzawa
Journal:  Br J Cancer       Date:  2005-06-20       Impact factor: 7.640

7.  High resolution chromosome 3p, 8p, 9q and 22q allelotyping analysis in the pathogenesis of gallbladder carcinoma.

Authors:  I I Wistuba; A Maitra; R Carrasco; M Tang; P Troncoso; J D Minna; A F Gazdar
Journal:  Br J Cancer       Date:  2002-08-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.